Loading clinical trials...
Loading clinical trials...
A Pilot Study of GRN1005 for Resectable Brain Metastases in Patients With Breast Cancer and Non-Small Cell Lung Cancer
Conditions
Interventions
Trastuzumab
GRN 1005
Start Date
August 29, 2012
Primary Completion Date
August 11, 2014
Completion Date
August 11, 2014
Last Updated
November 15, 2019
NCT05372640
NCT05673200
NCT04550494
NCT05245812
NCT04704661
NCT07483307
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions